Publication | Closed Access
L-carnitine reduces plasma lipoprotein(a) levels in patients with hyper Lp(a).
57
Citations
0
References
2000
Year
L-carnitine offers a potentially useful therapeutic agent for atherogenic conditions characterized by high Lp(a) levels, also in view of the excellent tolerability and essential lack of major side effects.